Name | ML-192 |
---|---|
Synonyms |
2-furanyl-[4-(2-methyl-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl)-1-piperazinyl]methanone
Furan-2-yl-[4-(2-methyl-5,6,7,8-tetrahydro-benzo[4,5]thieno[2,3-d]pyrimidin-4-yl)-piperazin-1-yl]-methanone ML-192 2-Furyl[4-(2-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-yl)-1-piperazinyl]methanone Methanone, 2-furanyl[4-(5,6,7,8-tetrahydro-2-methyl[1]benzothieno[2,3-d]pyrimidin-4-yl)-1-piperazinyl]- |
Description | ML192 is a selective ligand antagonist of GPR55. ML192 inhibits the β-arrestin trafficking, ERK1/2 phosphorylation and PKCβII translocation[1]. |
---|---|
Related Catalog | |
Target |
ERK2 ERK1 PKCβII |
In Vitro | ML192 抑制 10 μM L-α 溶血磷脂酰肌醇 (LPI) 或 1 μM ML186 诱导的 β-arrestin 转运,IC50 值分别为0.70μM、0.29 µM[1]。 ML192 显著抑制表达 GPRSS 的 U2OS 细胞中 ERK1/2 的磷酸化[1]。 ML192 (0, 10, 30 和 100 µM) 减弱了野生型 GPR55 受体细胞中的 PKCβII 易位[1]。 |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Molecular Formula | C20H22N4O2S |
Molecular Weight | 382.479 |
Exact Mass | 382.146332 |
LogP | 3.07 |
Index of Refraction | 1.664 |
Storage condition | 2-8°C |